SCL, LMO1 and Notch1 Reprogram Thymocytes into Self-Renewing Cells

• Bastien Gerby ,

  Contributed equally to this work with: Bastien Gerby, Cedric S. Tremblay, Mathieu Tremblay

  Affiliations Institute of Research in Immunology and Cancer – University of Montreal, Montreal, Quebec, Canada, Molecular Biology Program, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada

  ⨯
• Cedric S. Tremblay ,

  Contributed equally to this work with: Bastien Gerby, Cedric S. Tremblay, Mathieu Tremblay

  Current address: Australian Centre for Blood Diseases (ACBD), Monash University, Melbourne, Victoria, Australia

  Affiliations Institute of Research in Immunology and Cancer – University of Montreal, Montreal, Quebec, Canada, Molecular Biology Program, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada

  ⨯
• Mathieu Tremblay ,

  Contributed equally to this work with: Bastien Gerby, Cedric S. Tremblay, Mathieu Tremblay

  Affiliations Institute of Research in Immunology and Cancer – University of Montreal, Montreal, Quebec, Canada, Molecular Biology Program, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada

  ⨯
• Shanti Rojas-Sutterlin,

  Affiliations Institute of Research in Immunology and Cancer – University of Montreal, Montreal, Quebec, Canada, Molecular Biology Program, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada

  ⨯
• Sabine Herblot,

  Current address: Pediatrics Department, Faculty of Medicine, University of Montreal, and Charles-Bruneau cancer centre, Sainte-Justine Hospital, Montréal, Québec, Canada

  Affiliation Institute of Research in Immunology and Cancer – University of Montreal, Montreal, Quebec, Canada

  ⨯
• Josée Hébert,

  Affiliations Institute of Research in Immunology and Cancer – University of Montreal, Montreal, Quebec, Canada, Molecular Biology Program, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada, Maisonneuve-Rosemont Hospital. Montreal, Quebec, Canada

  ⨯
• Guy Sauvageau,

  Affiliations Institute of Research in Immunology and Cancer – University of Montreal, Montreal, Quebec, Canada, Molecular Biology Program, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada, Maisonneuve-Rosemont Hospital. Montreal, Quebec, Canada

  ⨯
• Sébastien Lemieux,

  Affiliations Institute of Research in Immunology and Cancer – University of Montreal, Montreal, Quebec, Canada, Molecular Biology Program, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada

  ⨯
• Eric Lécuyer,

  Affiliations Clinical Research Institute of Montreal (IRCM), Montreal, Quebec, Canada, Department of Biochemistry, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada

  ⨯
• Diogo F. T. Veiga,

  Affiliations Institute of Research in Immunology and Cancer – University of Montreal, Montreal, Quebec, Canada, Molecular Biology Program, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada

  ⨯
• Trang Hoang

  * E-mail: trang.hoang@umontreal.ca

  Affiliations Institute of Research in Immunology and Cancer – University of Montreal, Montreal, Quebec, Canada, Molecular Biology Program, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada, Department of Biochemistry, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada, Department of Pharmacology, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada

  ⨯